Resmetirom Produces NASH Resolution and Decreases Fibrosis: Results from the MAESTRO-NASH Trial
Evidence-Based GI: An ACG Publication and Podcast - En podkast av American College of Gastroenterology - Onsdager
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Nicole Rich, MD, MSCS discuss “A phase 3, randomized controlled trial of resmetirom in NASH with liver fibrosis,” by Harrison SA, Bedossa P, Guy CD et al. NEJM 2024; 390(6): 497-509.
